CO-LIGATION OF MOUSE COMPLEMENT RECEPTOR-1 AND RECEPTOR-2 WITH SURFACE IGM RESCUES SPLENIC B-CELLS AND WEHT-231 CELLS FROM ANTISURFACE IGM-INDUCED APOPTOSIS

被引:54
作者
KOZONO, Y
DUKE, RC
SCHLEICHER, MS
HOLERS, VM
机构
[1] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV RHEUMATOL,DENVER,CO 80262
[2] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV ONCOL,DENVER,CO 80262
[3] UNIV COLORADO,HLTH SCI CTR,DEPT IMMUNOL,DENVER,CO
关键词
COMPLEMENT; APOPTOSIS B LYMPHOCYTES; RECEPTOR; WEHI-231;
D O I
10.1002/eji.1830250423
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies have shown that complement receptors play important roles in both T-dependent and T-independent B lymphocyte responses to low doses of antigen (Ag) in vivo. Complement activation by either the classical or alternative pathway results in the covalent binding of C3 molecules to Ag in forms that ligate complement receptors type 1 (CR1) and 2 (CR2). We hypothesized that C3-bound Ag might cross-link CR2 and/or CR1 with surface (s)IgM and alter the signal that would be transduced through sIgM by Ag binding alone. One result of the altered signal could be the rescue of B lymphocytes from apoptosis that would otherwise be induced by the binding of certain types of Ag alone. We find that co-cross-linking of mouse CR2 and CR1 with sIgM rescues both resting B cells and WEHI-231.7 cells from apoptosis induced by sIgM ligation in a fashion similar to that found using soluble mouse CD40 ligand (mCD40L). Anti-CR2/CR1-mediated rescue requires co-cross-linking of the receptors with sIgM, and has an additive effect on mCD40L-mediated apoptosis rescue. Based on these results, it is likely that the CR2/CR1-derived signal is cooperative with T cell-derived signals such as CD40L and interleukin-4.
引用
收藏
页码:1013 / 1017
页数:5
相关论文
共 33 条
  • [1] ANTIIMMUNOGLOBULINS INDUCE DEATH BY APOPTOSIS IN WEHI-231 B-LYMPHOMA CELLS
    BENHAMOU, LE
    CAZENAVE, PA
    SARTHOU, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (06) : 1405 - 1407
  • [2] BONNEFOY JY, 1993, EUR J IMMUNOL, V23, P969
  • [3] BOTTGER EC, 1986, J IMMUNOL, V137, P1280
  • [4] BOYD AW, 1981, J IMMUNOL, V126, P2461
  • [5] CD19 - LOWERING THE THRESHOLD FOR ANTIGEN RECEPTOR STIMULATION OF LYMPHOCYTES-B
    CARTER, RH
    FEARON, DT
    [J]. SCIENCE, 1992, 256 (5053) : 105 - 107
  • [6] CARTER RH, 1988, J IMMUNOL, V141, P457
  • [7] DUKE RC, 1992, CURRENT PROTOCOLS IM
  • [8] GOLD MR, 1994, ADV IMMUNOL, V55, P221
  • [9] IMMUNOGLOBULIN PRODUCTION BY MURINE B-LYMPHOMA CELLS
    GUTMAN, GA
    WARNER, NL
    HARRIS, AW
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1981, 18 (02): : 230 - 244
  • [10] HAGGERTY HG, 1993, J IMMUNOL, V151, P4681